Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GY.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HH.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KN.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.332NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JB.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.86.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JW.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.100NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.43.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EU.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.48NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EK.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.19.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.479NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.437NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.371NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HU.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JC.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.214NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.284NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.351.3 (Beta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.318NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
R.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19749.2South Korea
AY.29 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ML.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.283NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.145NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.547NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.247NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.205NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.110NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.434NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.181NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used